BRIDGEWATER, N.J., April 27, 2018 /PRNewswire/ — Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, subject to Amneal and Impax’s agreement to divest…
Amneal And Impax Receive FTC Clearance For Business Combination
by Market News | Apr 27, 2018 | Blog